BBC | Virtus LifeSci Biotech Clinical Trials ETF Overview

(Stock Exchange: AMEX)

Day's Range	N/A - N/A
52 Week Range	N/A - N/A
Beta	0.91
Implied Volatility	27.38%
IV Rank	34.50%
Day's Volume	N/A
Average Volume	N/A
Shares Outstanding	N/A
Inception Date	2014-12-17

Assets	10,385,303
Asset Class	Equity
Expense Ratio	0.79
P/E Ratio	N/A
EPS	N/A
Dividend Yield	1.22%
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

*Chart delayed

Watching at BBC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BBC Technicals page.